References
- Nelson DE, Jarman DW, Rehm J, et al. Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health 2013;103:641–648.
- Voelker R. Even low, regular alcohol use increases the risk of dying of cancer. JAMA 2013;309:970.
- Tramacere I, Pelucchi C, Bonifazi M, et al. Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis. Ann Oncol 2012;23:2791–2798.
- Tramacere I, Pelucchi C, Bonifazi M, et al. A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma. Eur J Cancer Prev 2012;21:268–273.
- Kyle RA, Rajkumar SV. Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol 2007;20:637–664.
- Alexander DD, Mink PJ, Adami HO, et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 2007;120(Suppl. 12):40–61.
- Rota M, Porta L, Pelucchi C, et al. Alcohol drinking and multiple myeloma risk—a systematic review and meta-analysis of the dose-risk relationship. Eur J Cancer Prev 2014;23:113–121.
- World Cancer Research Fund. [Diet and cancer report website.] 2013. Available from: www.dietandcancerreport.org/
- Hamling J, Lee P, Weitkunat R, et al. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008;27:954–970.
- Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. 2011. The Cochrane Collaboration. Available from: http://handbook.cochrane.org/
- Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology 1993;4:218–228.
- Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada. 2011. Available from: www.ohri.ca/programs/clinical_epidemiology/oxford.htm
- Rota M, Bellocco R, Scotti L, et al. Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma. Stat Med 2010;29:2679–2687.
- Kwo PY, Ramchandani VA, O’Connor S, et al. Gender differences in alcohol metabolism: relationship to liver volume and effect of adjusting for body mass. Gastroenterology 1998;115:1552–1557.
- Cole-Harding S, Wilson JR. Ethanol metabolism in men and women. J Stud Alcohol 1987;48:380–387.
- Andersson A, Wirehn AB, Olvander C, et al. Alcohol use among university students in Sweden measured by an electronic screening instrument. BMC Public Health 2009;9:229.
- Cowan JM Jr, Weathermon A, McCutcheon JR, et al. Determination of volume of distribution for ethanol in male and female subjects. J Anal Toxicol 1996;20:287–290.
- Seitz HK, Egerer G, Simanowski UA, et al. Human gastric alcohol dehydrogenase activity: effect of age, sex, and alcoholism. Gut 1993;34:1433–1437.
- Moreno A, Pares A, Ortiz J, et al. Alcohol dehydrogenase from human stomach: variability in normal mucosa and effect of age, gender, ADH3 phenotype and gastric region. Alcohol Alcohol 1994; 29:663–671.
- Tuyns AJ, Pequignot G. Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol 1984;13:53–57.
- Chang ET, Clarke CA, Canchola AJ, et al. Alcohol consumption over time and risk of lymphoid malignancies in the California Teachers Study cohort. Am J Epidemiol 2010;172:1373–1383.
- Diaz LE, Montero A, Gonzalez-Gross M, et al. Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr 2002;56(Suppl. 3):S50–S53.
- Szabo G. Consequences of alcohol consumption on host defence. Alcohol Alcohol 1999;34:830–841.
- Furuya DT, Binsack R, Machado UF. Low ethanol consumption increases insulin sensitivity in Wistar rats. Braz J Med Biol Res 2003; 36:125–130.
- Hagner PR, Mazan-Mamczarz K, Dai B, et al. Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction. Blood 2009;113:5526–5535.
- Arranz S, Chiva-Blanch G, Valderas-Martinez P, et al. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients 2012;4:759–781.
- Lachenmeier DW, Godelmann R, Witt B, et al. Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic dose-response assessment.Int J Cancer 2014;134:144–153.
- Blanco-Colio LM, Munoz-Garcia B, Martin-Ventura JL, et al. Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet. Atherosclerosis 2007;192:335–341.
- Bhardwaj A, Sethi G, Vadhan-Raj S, et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 2007;109:2293–2302.
- ClinicalTrials.gov. A clinical study to assess the safety and activity of SRT501 alone or in combination with bortezomib in patients with multiple myeloma. 2012. Available from:http://clinicaltrials.gov/ct2/show/NCT00920556
- Mullan RJ, Flynn DN, Carlberg B, et al. Systematic reviewers commonly contact study authors but do so with limited rigor. J Clin Epidemiol 2009;62:138–142.
- Schwartzbaum J, Ahlbom A, Feychting M. Berkson's bias reviewed. Eur J Epidemiol 2003;18:1109–1112.
- Kanda J, Matsuo K, Inoue M, et al. Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center-based Prospective Study). Cancer Epidemiol Biomarkers Prev 2010;19:429–434.
- Ozasa K. Alcohol use and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev 2007;8(Suppl.):81–88.